Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationPharmazie. 2008, 63(3):171-9
AbstractDrug delivery to the posterior segment of the eye is important for potentially treating various disorders in retina, choroid, vitreous humor and optic nerve. Due to anatomic membrane barriers and the lacrimal drainage it can be quite challenging to obtain therapeutic drug concentrations in the posterior parts of the eye after topical drug administration. Since the membrane barriers cannot be altered with non-invasive methods invasive methods such as direct drug injection into the vitreous humor and subconjunctival, subtenons capsule or suprascleral injections are gaining popularity. However, invasive methods can cause discomfort for the patient and can also lead to complications that are even more serious than the disease being treated. Alternatively, novel ophthalmic formulations can be developed that specifically target topical drug delivery to the posterior segment of the eye. Anatomical and physiological barriers in the eye are reviewed as well as the theoretical model of passive drug diffusion from the eye surface into the eye. It is shown that enhanced drug delivery through conjunctiva/sclera to retina can be obtained by formulating lipophilic drugs as hydrophilic drug/cyclodextrin complex solutions. Optimization of the delivery system by formulating the drug as a low-viscosity aqueous drug/cyclodextrin complex suspension results in sustained high concentrations of dissolved drug in the tear fluid which further increases the targeted drug delivery to the posterior segment.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
- Authors: Loftsson T, Hreinsdóttir D, Stefánsson E
- Issue date: 2007 May
- A pharmacokinetic model for ocular drug delivery.
- Authors: Tojo K
- Issue date: 2004 Nov
- Drug delivery to the posterior segment of the eye.
- Authors: Thrimawithana TR, Young S, Bunt CR, Green C, Alany RG
- Issue date: 2011 Mar
- Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
- Authors: Myles ME, Neumann DM, Hill JM
- Issue date: 2005 Dec 13
- Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
- Authors: Ranta VP, Urtti A
- Issue date: 2006 Nov 15